100
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Antiangiogenic and antitumor effects of IMMUNEPOTENT CRP in murine melanoma

, , , , , , , , , , & show all
Pages 637-646 | Received 30 Nov 2009, Accepted 29 Jan 2010, Published online: 05 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Moises A. Franco-Molina, Silvia E. Santana-Krímskaya, Erika E. Coronado-Cerda, Carlos Eduardo Hernández-Luna, Diana G. Zarate-Triviño, Pablo Zapata-Benavides, Edgar Mendoza-Gamboa, María C. Rodríguez-Salazar, Reyes Tamez-Guerra & Cristina Rodríguez-Padilla. (2018) Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment. Biotechnology & Biotechnological Equipment 32:4, pages 1028-1035.
Read now
Moises A. Franco-Molina, Edgar Mendoza-Gamboa, Erika E. Coronado-Cerda, Diana Zarate-Triviño, Juan E. Arizpe-Coronado, Pablo Zapata-Benavides, Yareellys Ramos Zayas, Reyes Tamez-Guerra & Cristina Rodríguez-Padilla. (2017) Clinical trial evaluating the effectiveness of biocompound IMMUNEPOTENT CRP in the third-molar extraction. Biotechnology & Biotechnological Equipment 31:1, pages 182-186.
Read now

Articles from other publishers (12)

Moisés Armides Franco-Molina, Silvia Elena Santana-Krímskaya, Diana Ginette Zarate-Triviño, Pablo Zapata-Benavides, Sara Paola Hernández-Martínez, Fernanda Cervantes-Wong & Cristina Rodríguez-Padilla. (2021) Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product. Applied Sciences 11:8, pages 3505.
Crossref
Alejandra Reyes-Ruiz, Kenny Misael Calvillo-Rodriguez, Ana Carolina Martínez-Torres & Cristina Rodríguez-Padilla. (2021) The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory. British Journal of Cancer 124:8, pages 1398-1410.
Crossref
Ana Carolina Martínez-Torres, Alejandra Reyes-Ruiz, Kenny Misael Calvillo-Rodriguez, Karla Maria Alvarez-Valadez, Ashanti C. Uscanga-Palomeque, Reyes S. Tamez-Guerra & Cristina Rodríguez-Padilla. (2020) IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells. BMC Cancer 20:1.
Crossref
Ana Carolina Martinez-Torres, Luis Gomez-Morales, Alan B. Martinez-Loria, Ashanti Concepcion Uscanga-Palomeque, Jose Manuel Vazquez-Guillen & Cristina Rodriguez-Padilla. (2019) Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines. PeerJ 7, pages e7759.
Crossref
Ana Carolina Martínez-Torres, Alejandra Reyes-Ruiz, Milena Benítez-Londoño, Moises Armides Franco-Molina & Cristina Rodríguez-Padilla. (2018) IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production. BMC Cancer 18:1.
Crossref
Miguel A. Hernández-Esquivel, Armando Pérez-Torres, Laura Romero-Romero, Alonso Reyes-Matute, Brenda Loaiza, Gabriela Mellado-Sánchez, Lenin Pavón, Emilio Medina-Rivero, Richard G. Pestell, Sonia M. Pérez-Tapia & Marco A. Velasco-Velázquez. (2018) The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. Biomedicine & Pharmacotherapy 101, pages 938-944.
Crossref
Maria del Carmen Rodríguez-Salazar, Moises Armides Franco-Molina, Edgar Mendoza-Gamboa, Ana Carolina Martínez-Torres, Pablo Zapata-Benavides, Jose Sullivan López-González, Erika Evangelina Coronado-Cerda, Juan Manuel Alcocer-González, Reyes Silvestre Tamez-Guerra & Cristina Rodríguez-Padilla. (2017) The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth. Oncology Letters 14:1, pages 844-852.
Crossref
Crystel A. Sierra-Rivera, Moisés A. Franco-Molina, Edgar Mendoza-Gamboa, Pablo Zapata-Benavides, Jesús Santaolalla-Tapia, Erika E. Coronado-Cerda, Reyes S. Tamez-Guerra & Cristina Rodríguez-Padilla. (2016) Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells. Oncology Letters 12:6, pages 4449-4460.
Crossref
Muhammad Mujahid, Natasha Trendafilova, Agnieszka Foltyn Arfa-Kia, Georgina Rosair, Kevin Kavanagh, Michael Devereux, Maureen Walsh, Siobhán McClean, Bernadette S. Creaven & Ivelina Georgieva. (2016) Novel silver(I) complexes of coumarin oxyacetate ligands and their phenanthroline adducts: Biological activity, structural and spectroscopic characterisation. Journal of Inorganic Biochemistry 163, pages 53-67.
Crossref
Muhammad Mujahid, Agnieszka Foltyn-Arfa Kia, Brian Duff, Denise A. Egan, Michael Devereux, Siobhán McClean, Maureen Walsh, Natasha Trendafilova, Ivelina Georgieva & Bernadette S. Creaven. (2015) Spectroscopic studies, DFT calculations, and cytotoxic activity of novel silver(I) complexes of hydroxy ortho-substituted-nitro-2H-chromen-2-one ligands and a phenanthroline adduct. Journal of Inorganic Biochemistry 153, pages 103-113.
Crossref
Emilio Medina-Rivero, Giovanna Merchand-Reyes, Lenin Pavón, Said Vázquez-Leyva, Gilberto Pérez-Sánchez, Nohemí Salinas-Jazmín, Sergio Estrada-Parra, Marco Velasco-Velázquez & Sonia Mayra Pérez-Tapia. (2014) Batch-to-batch reproducibility of Transferon™. Journal of Pharmaceutical and Biomedical Analysis 88, pages 289-294.
Crossref
Tomohiko Sasaki, Satoru Motoyama, Yusuke Sato, Kei Yoshino, Goichi Matsumoto, Yoshihiro Minamiya, Hajime Saito, Katsuyuki Murata & Jun-ichi Ogawa. (2013) C-reactive protein inhibits lymphangiogenesis and resultant lymph node metastasis of squamous cell carcinoma in mice. Surgery 154:5, pages 1087-1092.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.